HealthDay on MSN9h
New Hope Against Breast Cancers That Spread to the BrainA recently approved targeted chemotherapy drug can significantly extend the lives of advanced breast cancer patients who have ...
11h
Loose Women panellist Nadia Sawalha has been campaigning for the life-changing drug Enhertu to be made available in Wales, ...
EXCLUSIVE: Loose Women star Nadia Sawalha has shared her heartbreak as she continues campaigning for the life-extending drug to be made available in England, Wales and Northern Ireland.
Enhertu improved the time it took for patients with a breast cancer subset to experience worsening pain and other symptoms, ...
The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic ...
Enhertu, a drug used to treat HER2-positive breast cancer, has seen its price rise eight times since 2019. This is especially ...
Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer: Tokyo Saturday, October 5, 2024, 10:00 Hrs [IST] Daiich ...
Daiichi Sankyo and AstraZeneca’s ENHERTU achieved a 61.6% progression-free survival rate at one year in patients with active or stable brain metastases in DESTINY-Breast12 Largest prospective ...
AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has ...
AstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has accepted the supplemental biologics license application (sBLA) seeking approval for expanded use of Enhertu for HER2-low ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback